Total Funding
76
86
Total FundingPost-IPO Equity raised
Growth Score 76 in past quarter
-2 pts
Heat Score 86 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9413
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
- Christian Hordo: Executive Vice President, Chief Business Officer
Michael Mee: Co-FounderPast Role: Flagship Pioneering, Senior Associate
About the Company
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.
Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases.
The company is a team of scientists, clinicians and biotechnology
veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.